Verifying…
Home / Drug A–Z / Sporidex Suspension 125 mg/5 mL

Sporidex Suspension 125 mg/5 mL

NAFDAC Reg. No. 04-1356 · Drug

Registered with NAFDAC — registration activeAs of 5 November 2026 · synced automatically from official sources.
Product
Sporidex Suspension 125 mg/5 mL
NAFDAC number
04-1356
Active ingredient
Cefalexin
Strength
125 mg/5 mL
Form
Suspension
Pack size
1 x 100 mL (in bottle)
Manufacturer
Not listed
Applicant (holder)
Ranbaxy Nigeria Limited
Approved
30 Jan 2025
Status
Active View on NAFDAC ↗
Registration valid to
29 Jan 2030
WHO alerts
None found
Community reports
None
Times checked
0

RxVerify commentary

  • Sporidex Suspension 125 mg/5 mL is on the NAFDAC register with an active registration (04-1356). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.

What Sporidex Suspension 125 mg/5 mL is used for

From the official U.S. FDA label for cefalexin, the active ingredient registered with NAFDAC.

What it is used for

Cephalexin capsules are a cephalosporin antibacterial drug indicated for the treatment of the following infections caused by susceptible isolates of designated bacteria: Respiratory tract infection ( 1.1 ) Otitis media ( 1.2 ) Skin and skin structure infections ( 1.3 ) Bone infections ( 1.4 ) Genitourinary tract infections ( 1.5 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules and other antibacterial drugs, cephalexin capsules should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. …

Possible side effects

The following serious events are described in greater detail in the Warning and Precautions section: Hypersensitivity reactions [see Warning and Precautions (5.1) ] Clostridium difficile -associated diarrhea [see Warnings and Precautions (5.2) ] Direct Coombs’ Test Seroconversion [see Warnings and Precautions (5.3) ] Seizure Potential [see Warnings and Precautions (5.4) ] Effect on Prothrombin Activity [see Warnings and Precautions (5.5) ] Development of Drug-Resistant Bacteria [see Warnings and Precautions (5.6) ] The most common adverse reactions associated with cephalexin include diarrhea, nausea, vomiting, dyspepsia and abdominal pain . …

Do not use if

Cephalexin capsules are contraindicated in patients with known hypersensitivity to cephalexin or other members of the cephalosporin class of antibacterial drugs. Patients with known hypersensitivity to cephalexin or other members of the cephalosporin class of antibacterial drugs. ( 4 )

Warnings

Serious hypersensitivity (anaphylactic) reactions : Prior to use, inquire regarding history of hypersensitivity to beta-lactam antibacterial drugs. Discontinue the drug if signs or symptoms of an allergic reaction occur and institute supportive measures. ( 5.1 ) Clostridium difficile -associated diarrhea (CDAD ): Evaluate if diarrhea occurs. ( 5.2 ) Direct Coombs’ Test Seroconversion : If anemia develops during or after cephalexin therapy, evaluate for drug-induced hemolytic anemia. ( 5.3 ) Seizure Potential : Use lower dose in patients with renal impairment. …

Pregnancy & breastfeeding

8.1 Pregnancy Risk Summary Available data from published epidemiologic studies and pharmacovigilance case reports over several decades with cephalosporin use, including cephalexin use in pregnant women have not established drug-associated risks of major birth defects, miscarriage, or adverse maternal or fetal outcomes (see Data) . …

General information only — not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

Check your pack of Sporidex Suspension 125 mg/5 mL

Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.

3 free checks left today · no signup Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About Sporidex Suspension 125 mg/5 mL

What is in Sporidex Suspension 125 mg/5 mL?

Sporidex Suspension 125 mg/5 mL contains Cefalexin (125 mg/5 mL), as suspension, according to its NAFDAC registration record.

Is Sporidex Suspension 125 mg/5 mL registered with NAFDAC?

Yes. Sporidex Suspension 125 mg/5 mL is listed on the NAFDAC register under registration number 04-1356, and its registration is active as of 5 November 2026.

Has Sporidex Suspension 125 mg/5 mL been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Sporidex Suspension 125 mg/5 mL in our automatically synced alert list.

How can I check that my pack of Sporidex Suspension 125 mg/5 mL is genuine?

Run a free authenticity scan with the NAFDAC number 04-1356, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is Sporidex Suspension 125 mg/5 mL used for?

Cephalexin capsules are a cephalosporin antibacterial drug indicated for the treatment of the following infections caused by susceptible isolates of designated bacteria: Respiratory tract infection ( 1.1 ) Otitis media ( 1.2 ) Skin and skin structure infections ( 1.3 ) Bone infections ( 1.4 ) Genitourinary tract infections ( 1.5 ) To reduce the development of drug-resistant bacteria and maintain t (Summarised from the official U.S. FDA label for cefalexin. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Sporidex Suspension 125 mg/5 mL? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.